TRIM37 promotes gallbladder cancer proliferation by activating the Wnt/β-catenin pathway via ubiquitination of Axin1

Background: Gallbladder cancer (GBC) is among the most lethal malignancies in the world, with a prognosis that is extremely poor. The results of previous studies suggest that tripartite motif containing 37 (TRIM37) contributes to the progression of numerous types of cancer. Nevertheless, there is li...

Full description

Bibliographic Details
Main Authors: Ming Xu, Bowen Jiang, Zhongran Man, Hongyi Zhu
Format: Article
Language:English
Published: Elsevier 2023-09-01
Series:Translational Oncology
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S1936523323001183
_version_ 1797778411494572032
author Ming Xu
Bowen Jiang
Zhongran Man
Hongyi Zhu
author_facet Ming Xu
Bowen Jiang
Zhongran Man
Hongyi Zhu
author_sort Ming Xu
collection DOAJ
description Background: Gallbladder cancer (GBC) is among the most lethal malignancies in the world, with a prognosis that is extremely poor. The results of previous studies suggest that tripartite motif containing 37 (TRIM37) contributes to the progression of numerous types of cancer. Nevertheless, there is little knowledge about the molecular mechanisms and functions of TRIM37 in GBC. Methods: A clinical significance assessment was conducted on TRIM37 following its detection by immunohistochemistry. In vitro and in vivo functional assays were performed to investigate the role of TRIM37 in GBC. Results: In this study, TRIM37 is upregulated in GBC tissues, which is associated with decreased histological differentiation, advanced TNM stage, and shorter overall survival rates. In vitro, TRIM37 knockdown inhibited cell proliferation and promoted apoptosis, and in vivo, TRIM37 knockdown suppressed GBC growth. Contrary to this, cell proliferation is increased in GBC cells when overexpression of TRIM37 is expressed. Mechanistic investigations revealed that TRIM37 promotes GBC progression through activation of the Wnt/β‑catenin signaling pathway via degradation of Axin1. Conclusion: The present study suggests that TRIM37 contributes to the development of GBC and thus provides an important biomarker for predicting GBC prognosis and an effective target for therapeutic intervention.
first_indexed 2024-03-12T23:17:54Z
format Article
id doaj.art-ed64606a3a4a40deb8ecea65f648a1c8
institution Directory Open Access Journal
issn 1936-5233
language English
last_indexed 2024-03-12T23:17:54Z
publishDate 2023-09-01
publisher Elsevier
record_format Article
series Translational Oncology
spelling doaj.art-ed64606a3a4a40deb8ecea65f648a1c82023-07-17T04:07:36ZengElsevierTranslational Oncology1936-52332023-09-0135101732TRIM37 promotes gallbladder cancer proliferation by activating the Wnt/β-catenin pathway via ubiquitination of Axin1Ming Xu0Bowen Jiang1Zhongran Man2Hongyi Zhu3Department of Hepatobiliary Surgery, The First Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui, ChinaDepartment of Hepatobiliary Surgery, The First Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui, ChinaDepartment of Hepatobiliary Surgery, The First Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui, ChinaDepartment of Hepatobiliary Surgery, The First Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui, China; Department of Biliary-Pancreatic Surgery, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China; Corresponding author.Background: Gallbladder cancer (GBC) is among the most lethal malignancies in the world, with a prognosis that is extremely poor. The results of previous studies suggest that tripartite motif containing 37 (TRIM37) contributes to the progression of numerous types of cancer. Nevertheless, there is little knowledge about the molecular mechanisms and functions of TRIM37 in GBC. Methods: A clinical significance assessment was conducted on TRIM37 following its detection by immunohistochemistry. In vitro and in vivo functional assays were performed to investigate the role of TRIM37 in GBC. Results: In this study, TRIM37 is upregulated in GBC tissues, which is associated with decreased histological differentiation, advanced TNM stage, and shorter overall survival rates. In vitro, TRIM37 knockdown inhibited cell proliferation and promoted apoptosis, and in vivo, TRIM37 knockdown suppressed GBC growth. Contrary to this, cell proliferation is increased in GBC cells when overexpression of TRIM37 is expressed. Mechanistic investigations revealed that TRIM37 promotes GBC progression through activation of the Wnt/β‑catenin signaling pathway via degradation of Axin1. Conclusion: The present study suggests that TRIM37 contributes to the development of GBC and thus provides an important biomarker for predicting GBC prognosis and an effective target for therapeutic intervention.http://www.sciencedirect.com/science/article/pii/S1936523323001183Gallbladder cancerPrognosisTRIM37Axin1Wnt/β-catenin
spellingShingle Ming Xu
Bowen Jiang
Zhongran Man
Hongyi Zhu
TRIM37 promotes gallbladder cancer proliferation by activating the Wnt/β-catenin pathway via ubiquitination of Axin1
Translational Oncology
Gallbladder cancer
Prognosis
TRIM37
Axin1
Wnt/β-catenin
title TRIM37 promotes gallbladder cancer proliferation by activating the Wnt/β-catenin pathway via ubiquitination of Axin1
title_full TRIM37 promotes gallbladder cancer proliferation by activating the Wnt/β-catenin pathway via ubiquitination of Axin1
title_fullStr TRIM37 promotes gallbladder cancer proliferation by activating the Wnt/β-catenin pathway via ubiquitination of Axin1
title_full_unstemmed TRIM37 promotes gallbladder cancer proliferation by activating the Wnt/β-catenin pathway via ubiquitination of Axin1
title_short TRIM37 promotes gallbladder cancer proliferation by activating the Wnt/β-catenin pathway via ubiquitination of Axin1
title_sort trim37 promotes gallbladder cancer proliferation by activating the wnt β catenin pathway via ubiquitination of axin1
topic Gallbladder cancer
Prognosis
TRIM37
Axin1
Wnt/β-catenin
url http://www.sciencedirect.com/science/article/pii/S1936523323001183
work_keys_str_mv AT mingxu trim37promotesgallbladdercancerproliferationbyactivatingthewntbcateninpathwayviaubiquitinationofaxin1
AT bowenjiang trim37promotesgallbladdercancerproliferationbyactivatingthewntbcateninpathwayviaubiquitinationofaxin1
AT zhongranman trim37promotesgallbladdercancerproliferationbyactivatingthewntbcateninpathwayviaubiquitinationofaxin1
AT hongyizhu trim37promotesgallbladdercancerproliferationbyactivatingthewntbcateninpathwayviaubiquitinationofaxin1